Carlos Juan
Carlos Juan
Immunology associate professor (UIB), Microbiology Researcher Hospital Son Espases, Palma
Verified email at
Cited by
Cited by
The increasing threat of Pseudomonas aeruginosa high-risk clones
A Oliver, X Mulet, C López-Causapé, C Juan
Drug Resistance Updates 21, 41-59, 2015
β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein
B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver
PLoS Pathog 5 (3), e1000353, 2009
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals
O Gutiérrez, C Juan, E Cercenado, F Navarro, E Bouza, P Coll, JL Pérez, ...
Antimicrobial agents and chemotherapy 51 (12), 4329-4335, 2007
Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance
A Doménech-Sánchez, L Martínez-Martínez, S Hernández-Allés, ...
Antimicrobial agents and chemotherapy 47 (10), 3332-3335, 2003
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones
G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ...
Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012
Molecular mechanisms of β-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains
C Juan, MD Maciá, O Gutiérrez, C Vidal, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 49 (11), 4733-4738, 2005
Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and …
J Oteo, K Diestra, C Juan, V Bautista, Â Novais, M Pérez-Vázquez, ...
International journal of antimicrobial agents 34 (2), 173-176, 2009
Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level β-lactam resistance involves three AmpD homologues
C Juan, B Moyá, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 50 (5), 1780-1787, 2006
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
E Riera, G Cabot, X Mulet, M García-Castillo, R del Campo, C Juan, ...
Journal of antimicrobial chemotherapy 66 (9), 2022-2027, 2011
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC
G Cabot, S Bruchmann, X Mulet, L Zamorano, B Moyà, C Juan, ...
Antimicrobial agents and chemotherapy 58 (6), 3091-3099, 2014
Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections
A Oliver, BR Levin, C Juan, F Baquero, J Blázquez
Antimicrobial agents and chemotherapy 48 (11), 4226-4233, 2004
Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates
G Cabot, L Zamorano, B Moyà, C Juan, A Navas, J Blázquez, A Oliver
Antimicrobial agents and chemotherapy 60 (3), 1767-1778, 2016
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities
B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver
Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum β-lactamases GES-1 and GES-5 in Spain
E Viedma, C Juan, J Acosta, L Zamorano, JR Otero, F Sanz, F Chaves, ...
Antimicrobial agents and chemotherapy 53 (11), 4930-4933, 2009
Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones
C Juan, L Zamorano, A Mena, S Albertí, JL Pérez, A Oliver
Journal of antimicrobial chemotherapy 65 (3), 474-478, 2010
Activity of a new cephalosporin, CXA-101 (FR264205), against β-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of …
B Moya, L Zamorano, C Juan, JL Pérez, Y Ge, A Oliver
Antimicrobial agents and chemotherapy 54 (3), 1213-1217, 2010
Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa
B Moya, L Zamorano, C Juan, Y Ge, A Oliver
Antimicrobial agents and chemotherapy 54 (9), 3933-3937, 2010
Biological markers of Pseudomonas aeruginosa epidemic high-risk clones
X Mulet, G Cabot, AA Ocampo-Sosa, MA Domínguez, L Zamorano, ...
Antimicrobial agents and chemotherapy 57 (11), 5527-5535, 2013
Benefit of having multiple ampD genes for acquiring β-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa
B Moya, C Juan, S Alberti, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 52 (10), 3694-3700, 2008
Characterization of the new metallo-β-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain
C Juan, A Beceiro, O Gutiérrez, S Albertí, M Garau, JL Pérez, G Bou, ...
Antimicrobial agents and chemotherapy 52 (10), 3589-3596, 2008
The system can't perform the operation now. Try again later.
Articles 1–20